Neuehealth Stock Analysis

NEUE Stock   4.77  0.00  0.00%   
NeueHealth is undervalued with Real Value of 9.53 and Target Price of 24.33. The main objective of NeueHealth stock analysis is to determine its intrinsic value, which is an estimate of what NeueHealth is worth, separate from its market price. There are two main types of NeueHealth's stock analysis: fundamental analysis and technical analysis.
The NeueHealth stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and NeueHealth's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.

NeueHealth Stock Analysis Notes

About 64.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. NeueHealth had 1:80 split on the 22nd of May 2023. To find out more about NeueHealth contact George III at 612 238 1321 or learn more at https://www.neuehealth.com.

NeueHealth Quarterly Total Revenue

232.93 Million

NeueHealth Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. NeueHealth's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding NeueHealth or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
NeueHealth generated a negative expected return over the last 90 days
NeueHealth has high historical volatility and very poor performance
NeueHealth has a very high chance of going through financial distress in the upcoming years
NeueHealth was previously known as Bright Health Group and was traded on New York Stock Exchange under the symbol BHG.
The company reported the previous year's revenue of 1.16 B. Net Loss for the year was (1.15 B) with profit before overhead, payroll, taxes, and interest of 0.
NeueHealth generates negative cash flow from operations
NeueHealth has a frail financial position based on the latest SEC disclosures
About 64.0% of the company shares are owned by institutional investors
Latest headline from prnewswire.com: SIGEP WORLD CHRISTMAS OBSERVATORY BY IEG NEUE IDEEN UND TRENDS FR DIE FESTLICHE TAFEL

NeueHealth Upcoming and Recent Events

6th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

NeueHealth Largest EPS Surprises

Earnings surprises can significantly impact NeueHealth's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-05-04
2022-03-31-0.2418-0.32-0.078232 
2021-08-03
2021-06-30-0.1598-0.28-0.120275 
2022-08-10
2022-06-30-0.3225-0.45-0.127539 
View All Earnings Estimates

NeueHealth Environmental, Social, and Governance (ESG) Scores

NeueHealth's ESG score is a quantitative measure that evaluates NeueHealth's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of NeueHealth's operations that may have significant financial implications and affect NeueHealth's stock price as well as guide investors towards more socially responsible investments.

NeueHealth Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.8 M.

NeueHealth Profitablity

The company has Profit Margin (PM) of (0.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.02)(0.97)
Return On Capital Employed 3.48  3.65 
Return On Assets(0.94)(0.89)
Return On Equity 3.35  3.52 

Management Efficiency

NeueHealth has return on total asset (ROA) of (0.0358) % which means that it has lost $0.0358 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8326) %, meaning that it created substantial loss on money invested by shareholders. NeueHealth's management efficiency ratios could be used to measure how well NeueHealth manages its routine affairs as well as how well it operates its assets and liabilities. At present, NeueHealth's Return On Equity is projected to increase slightly based on the last few years of reporting. At present, NeueHealth's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.32, whereas Non Current Assets Total are forecasted to decline to about 129.7 M.
Last ReportedProjected for Next Year
Book Value Per Share(32.01)(30.41)
Tangible Book Value Per Share(43.73)(41.55)
Enterprise Value Over EBITDA(0.62)(0.65)
Price Book Value Ratio(0.19)(0.20)
Enterprise Value Multiple(0.62)(0.65)
Price Fair Value(0.19)(0.20)
Enterprise Value1.4 B1.3 B
NeueHealth benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Operating Margin
(0.16)
Profit Margin
(0.99)
Beta
0.855
Return On Assets
(0.04)
Return On Equity
(1.83)

Technical Drivers

As of the 28th of November, NeueHealth secures the Mean Deviation of 2.34, downside deviation of 3.13, and Risk Adjusted Performance of 0.0196. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NeueHealth, as well as the relationship between them. Please verify NeueHealth jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if NeueHealth is priced some-what accurately, providing market reflects its recent price of 4.77 per share. Given that NeueHealth has jensen alpha of 0.0276, we recommend you to check NeueHealth's last-minute market performance to make sure the company can sustain itself at a future point.

NeueHealth Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NeueHealth middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NeueHealth. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

NeueHealth Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NeueHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on NeueHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NeueHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Mikan George Lawrence Iii over three weeks ago
Disposition of 4990 shares by Mikan George Lawrence Iii of NeueHealth at 7.27 subject to Rule 16b-3
 
Jay Matushak over a month ago
Disposition of tradable shares by Jay Matushak of NeueHealth at 5.18 subject to Rule 16b-3
 
Jay Matushak over a month ago
Disposition of 263 shares by Jay Matushak of NeueHealth subject to Rule 16b-3
 
New Enterprise Associates 15, L.p. over a month ago
Acquisition by New Enterprise Associates 15, L.p. of 61865 shares of NeueHealth at 0.01 subject to Rule 16b-3
 
Jay Matushak over three months ago
Acquisition by Jay Matushak of 978 shares of NeueHealth subject to Rule 16b-3
 
Tomas Orozco over three months ago
Disposition of tradable shares by Tomas Orozco of NeueHealth at 7.1 subject to Rule 16b-3
 
Robert Sheehy over six months ago
Disposition of 4755 shares by Robert Sheehy of NeueHealth subject to Rule 16b-3
 
Makhzoumi Mohamad over six months ago
Acquisition by Makhzoumi Mohamad of 4755 shares of NeueHealth subject to Rule 16b-3
 
Adkins Kedrick D Jr over six months ago
Disposition of 4755 shares by Adkins Kedrick D Jr of NeueHealth subject to Rule 16b-3
 
Jay Matushak over six months ago
Disposition of 317 shares by Jay Matushak of NeueHealth at 6.05 subject to Rule 16b-3
 
Mikan George Lawrence Iii over six months ago
Acquisition by Mikan George Lawrence Iii of 0000 shares of NeueHealth subject to Rule 16b-3
 
New Enterprise Associates 15, L.p. over six months ago
Acquisition by New Enterprise Associates 15, L.p. of 123729 shares of NeueHealth at 0.01 subject to Rule 16b-3

NeueHealth Outstanding Bonds

NeueHealth issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NeueHealth uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NeueHealth bonds can be classified according to their maturity, which is the date when NeueHealth has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

NeueHealth Predictive Daily Indicators

NeueHealth intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NeueHealth stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

NeueHealth Corporate Filings

8K
7th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
30th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
8th of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
3rd of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10Q
13th of August 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
7th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

NeueHealth Forecast Models

NeueHealth's time-series forecasting models are one of many NeueHealth's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NeueHealth's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About NeueHealth Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how NeueHealth prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NeueHealth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NeueHealth. By using and applying NeueHealth Stock analysis, traders can create a robust methodology for identifying NeueHealth entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.54)(0.57)
Operating Profit Margin(0.50)(0.52)
Net Loss(0.99)(1.04)
Gross Profit Margin 0.14  0.10 

Current NeueHealth Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. NeueHealth analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. NeueHealth analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
24.33Hold2Odds
NeueHealth current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most NeueHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NeueHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NeueHealth, talking to its executives and customers, or listening to NeueHealth conference calls.
NeueHealth Analyst Advice Details

NeueHealth Stock Analysis Indicators

NeueHealth stock analysis indicators help investors evaluate how NeueHealth stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading NeueHealth shares will generate the highest return on investment. By understating and applying NeueHealth stock analysis, traders can identify NeueHealth position entry and exit signals to maximize returns.
Begin Period Cash Flow1.9 B
Total Stockholder Equity-343.5 M
Property Plant And Equipment Net14.5 M
Cash And Short Term Investments93.6 M
Net Invested Capital-893.6 M
Cash87.3 M
50 Day M A6.7736
Net Interest Income-38.2 M
Total Current Liabilities1.4 B
Investments1.1 B
Interest Expense38.2 M
Stock Based Compensation83.7 M
Long Term Debt66.4 M
Common Stock Shares OutstandingM
Tax Provision-1.4 M
Free Cash Flow-2.7 B
Other Current Assets17.8 M
Accounts Payable169.7 M
Net Debt283 M
Depreciation24.2 M
Other Operating Expenses1.7 B
Non Current Assets Total136.6 M
Liabilities And Stockholders Equity1.2 B
Non Currrent Assets Other28.8 M

Complementary Tools for NeueHealth Stock analysis

When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital